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Abstract
Background: The occurrence of skeletal muscle metastases is a very rare event. Only two cases
of late skeletal muscle recurrence from cervical cancer have been documented until now.
Case presentation: A 38-year old patient, submitted to radical hysterectomy and pelvic
lymphadenectomy for a squamous FIGO stage IB1 cervical carcinoma, presented after 76 months
with a palpable, and painless swelling on the left hemithorax. MRI showed a nodule located in the
context of the intercostal muscles. Pathology revealed the presence of metastasis of squamous cell
carcinoma of similar morphology as the primary. On the basis of FDG-PET findings, which excluded
other sites of disease, surgical excision of the lesion was performed. The patient was triaged to
chemotherapy plus external radiotherapy.
Conclusion: A case of skeletal muscle recurrence from cervical cancer after a very long interval
from primary diagnosis is reported. Muscular pain or weakness, or just a palpable mass in a patient
with a history of cancer has always to raise the suspicion of muscle metastasis.
Background
The incidence of skeletal muscle metastases is reported to
be less than 1% of metastases of haematogenous origin,
despite the fact that skeletal muscle accounts for nearly
50% of the total body weight and is characterized by a rich
blood supply [1]. The reasons for the rarity of metastatic
involvement of skeletal muscle are still unclear, but sev-
eral hypotheses have been made including: a) the con-
stant movement of skeletal muscles, which may represent
a difficult condition for the implantation and growth of
metastatic cells under the high tissue pressure related to
the exercise associated increase of blood flow; b) the local
production of lactic acid, which would create an unfa-
vourable environment for metastatic cell growth; c) the
inhibition of cell invasion by protease inhibitors located
in the basement membrane; d) the antitumor activity of
lymphocytes and/or natural killer cells within the skeletal
muscle; e) in vivo evidences that skeletal muscle-delivered
peptidic factors may influence the metastatization process
[1]. Psoas, iliopsoas and paraspinal muscles, and proxi-
mal musculature of the upper and lower limbs, represent
the most frequently involved sites. Malignancies known
to frequently metastasize to the muscle are melanoma,
kidney, lung, thyroid cancer; moreover skeletal muscle
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metastases have been also reported in lymphoma, leukae-
mia and colon cancer patients [1].
To our knowledge, five cases of skeletal muscle metastasis
and two cases of skeletal muscle recurrence after 24 and
60 months fro initial diagnosis of cervical cancer have
been documented until now [2-9].
We report an unusual case of isolated intercostal muscle
recurrence after a very long interval from primary diagno-
sis of squamous cervical cancer. A review of the literature
with particular emphasis on the diagnostic and therapeu-
tic issues is also presented.
Case presentation
A 38-year old patient was admitted to the Gynaecologic
Oncology Unit of the Catholic University of Rome in June
1998 for irregular vaginal bleeding. Gynaecological exam-
ination revealed an ulcerated lesion (maximum diameter
= 3 cm) of the uterine cervix The histopathologic diagno-
sis of colposcopy-guided biopsy revealed the presence of
moderately differentiated squamous cell cervical carci-
noma. The patient was clinically staged as having FIGO
stage IB1 cervical cancer and was submitted to radical hys-
terectomy and pelvic lymphadenectomy. Final staging
was pT1bN0M0 according to TNM classification.
After 76 months from initial diagnosis, the patient pre-
sented with a palpable, painless, mobile and tender swell-
ing on the left side of the thorax approximately at the level
of the 5th rib. Ultrasonography was performed revealing
a subfascial hypoechogenic lesion (maximum diameter =
2 cm) within the intercostal muscles, close to the rib,
which however, appeared uninvolved (Figure 1A). Mag-
netic Resonance Imaging (MRI) study of the left rib cage
confirmed the presence of an intermediate intensity signal
area in both T1 and T2-weighted images, with a moderate
gadolinium-contrast enhancement, which was considered
consistent with a desmoid lesion (Figure 1B). Gynecolog-
ical examination as well as chest X-ray and MRI of the
abdomen and pelvis were normal, and circulating levels
of SCC were negative (0.8 ng/ml). Fine-needle aspiration
of the lesion was planned and revealed the presence of
squamous carcinoma cells. The patient was then investi-
gated by fluorodeoxyglucose positron emission tomogra-
phy (FDG-PET), which showed only two abnormal
uptakes of the radiotracer in the left hemithorax (Figure
1C). On the basis of FDG-PET findings, which excluded
other sites of metastatic disease, a wide surgical excision of
the lesion was performed and final pathology revealed the
presence of a nodule (maximum diameter = 1.7 cm) con-
sistent with metastasis of squamous cell carcinoma (Fig-
ure 1D) of similar morphology as the primary. The
surgical margins were free of disease.
After extensive counselling, the patient was triaged to
combined chemotherapy with carboplatin (5AUC) and
paclitaxel (175 mg/m2), plus external radiotherapy (total
dose = 4,000 cGy in 20 fractions) on the left hemi thorax.
After two months from the completion of treatment, the
patient shows no evidence of disease and does not com-
plain of any symptom related to radiation treatment.
Conclusion
We first reported a case of isolated intercostal cage muscle
recurrence after a very long interval from the diagnosis of
squamous cell carcinoma of the uterine cervix. As shown
in Table 1, skeletal muscle involvement from cervical car-
cinoma is very rare, and usually documented in the con-
text of an already far advanced stage tumor or metastatic
disease [6-8], or in severely immunocompromised
patients, as occurs in patients with AIDS [3,4]. In addi-
tion, an unusual case of involvement of masseter muscle
has been also described in a case with very aggressive his-
tology [5]. Although the association between specific
tumor histotypes and tendency to involve skeletal muscle
has been not determined, in lung cancer skeletal muscle
metastasis have been documented to more frequently
develop from adenosquamous cell carcinoma [10]. The
clinical outcome of patients with skeletal muscle metasta-
sis is generally poor [1,10], given the common finding of
diffuse metastatic disease. As shown in Table 1, most of
the data about the clinical course of cervical cancer
patients with skeletal muscle involvement is lacking.
Establishing the diagnosis of skeletal muscle metastasis
sometimes can be difficult: indeed, although skeletal mus-
cle metastases can be painful or palpable or cause deform-
ity according to location, sometimes they can be
asymptomatic. Indeed, our patient only complained of a
mobile, painless swelling, which could have been easily
underestimated given the long interval from initial diag-
nosis, the favourable clinical pathological characteristics
of disease (squamous histotype, FIGO stage IB1), and,
above all, the unusual and unexpected recurrence presen-
tation. Although the histopathological evaluation repre-
sents a more straight forward diagnostic approach,
diagnostic imaging techniques are useful tools in order to
define the site and extension of disease [11], and exclude
diffuse metastases. However, the differential diagnosis
between primary intramuscular tumor and metastasis,
which is a very important issue for patient prognosis and
clinical management, is not easy: in our case MRI showed
an intermediate signal area intensity on T1 and T2-
weighted scans, very similar to the muscle tissue but with
an important enhancement after the contrast injection.
None of the diagnostic tools used documented any signs
of the presence of necrosis or haemorrhage. which would
have been suggestive of a pattern of rapid growth. In this
context, much attention has been focused on the useful-BMC Cancer 2006, 6:169 http://www.biomedcentral.com/1471-2407/6/169
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ness of FDG-PET not only for staging, but also for the
detection of recurrence in cervical carcinoma: in our case
FDG-PET findings showed to be critical in order to plan
patient management since a diffuse metastatic disease was
excluded, and surgical removal of the intercostal muscle
recurrence could be planned. Given the very rare occur-
rence of skeletal muscle metastasis, there are no specific
guidelines on the therapeutic options, which include radi-
otherapy, chemotherapy and surgery according to the
clinical setting: indeed, the real benefit of these
approaches remains questionable given the very poor
prognosis of these patients. As shown in Table 1, in case
of a solitary and surgically resectable skeletal muscle
metastasis, metastasectomy has been performed, followed
by radiotherapy [9]. In our case the choice of a multimo-
dal approach was sustained by i)the young age of the
patient and her good performance status; i) the documen-
tation of a single and surgically amenable recurrence; ii)
the general consideration of skeletal muscle metastasis as
a marker of systemic disease, which would require chem-
otherapy: in particular the platinum-taxane combination
was chosen on the basis of the high response rate docu-
mented with this regimen with respect to cisplatin alone
[12]; the choice of using carboplatin instead of cisplatin
was motivated by the documentation of a better patient
convenience and tolerance together with the encouraging
A. Ultrasonography of the left thorax documenting a hypoechogenic nodule in the context of the intercostal muscle, close to  the underlying rib Figure 1
A. Ultrasonography of the left thorax documenting a hypoechogenic nodule in the context of the intercostal muscle, close to 
the underlying rib. The nodule shows intralesional vessels at Color Doppler examination. B. T1-weighted MRI showing the 
presence of a moderate gadolinium-contrast enhancement area in the intercostal muscle adjacent to the rib. C. FDG-PET/CT 
scan documenting two focuses of abnormal FDG uptake in the left hemithorax. D. Recurrence of squamous cell cervical carci-
noma in the rib cage muscle. The bands of skeletal muscle are separated and infiltrated by nests of squamous carcinoma cells 
surrounded by desmoplasic stroma and showing areas of keratinisation. (Hematoxylin & Eosin, magnification 100×).BMC Cancer 2006, 6:169 http://www.biomedcentral.com/1471-2407/6/169
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results obtained with carboplatin/paclitaxel regimen in
advanced/recurrent pre-irradiated cervical cancer patients
[13]. In addition, radiotherapy was planned in order to
achieve a better local control of disease, after balancing
and discussing with the patient the overall risk of pulmo-
nary fibrosis related to the specific site of irradiation.
In conclusion, we reported a case of a solitary distant skel-
etal muscle recurrence from early stage cervical cancer
after a very long interval from primary diagnosis. Late
recurrence (i.e. after a disease-free interval of more than 5
years) in cervical cancer patients is considered a very rare
event occurring in approximately 4% of cases with a fre-
quency increasing from 1.8% in stage I, to 5.2% and 8.5%
in stage II and III disease, respectively [14]. These figures
suggest that cervical cancer patients, especially those bear-
ing stage II-III disease warrant long follow up care,
because of the long period of tumor cell dormancy. In par-
ticular, muscular pain or weakness, or just a palpable mass
in a patient with a history of cervical cancer has always to
raise the suspicion of metastatic muscular disease.
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